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Endothelium-dependent vasodilation and oxidative stress in out renal disease. Available evidence suggests that an
chronic renal failure: Impact on cardiovascular disease. Despite excess risk of CVD is present very early in the natural
significant progress in renal replacement therapy, the mortality history of CRF and about 1/3 of patients with mild renalfrom cardiovascular disease (CVD) in patients with chronic
impairment (glomerular filtration rate [GFR]50) wererenal failure (CRF) is many times higher than in the general
found to have a history of overt CVD [2].population. The traditional risk factors are frequently present
in CRF patients. However, based upon conventional risk factor The traditional risk factors for CVD are frequently
analysis, these factors do not fully explain the extraordinary present in patients with CRF, such as age, sex, diabetes,
increase in morbidity and mortality in CVD among patients dyslipidemia, and hypertension. However, based uponwith CRF. Accumulating evidence suggests that CRF is associ-
conventional risk factor analysis, these factors would notated with impaired endothelial cell function.
fully explain the extraordinary increase in morbidity andIn recent years, the role of endothelial dysfunction (ED)
and excessive oxidative stress (OS) in the development of CVD mortality in CVD among patients with CRF.
has been highlighted. ED is an early feature of vascular disease In recent years, the role of nontraditional risk factors
in different diseases such diabetes, hypertension, hypercholes-
has been highlighted. Such factors include severe pro-terolemia, and coronary heart disease.
longed oxidative stress, endothelial dysfunction, malnu-The precise mechanism which induces ED is not clear. Sev-
eral factors however, including OS-related accumulation of trition, and chronic inflammation. This review focuses
uremic toxins, hypertension and shear stress, dyslipidemia with on the role of OS and ED in the development of CVD
cytotoxic lipoprotein species such as small, dense low-density in patients with CRF.
lipoprotein (LDL) particles, competitive inhibition of endothe-
lial nitric oxide (NO) by increased production by asymmetrical
dimethylarginine (ADMA) are pathogenic. OXIDATIVE STRESS ANDIn addition, it is known that excessive OS causes ED. An
ANTIOXIDANT DEFENSEoverproduction of reactive oxygen species (ROS) may injure
the endothelial cell membrane, inactivate NO, and cause oxida- Oxidative stress
tion of an essential cofactor of nitric oxide synthase (NOS).
OS has been defined as a disturbance in the balanceRecent studies have demonstrated that an impaired endothe-
lium-dependent vasodilation and OS are closely related to each between antioxidants and pro-oxidants, with increased
other in patients with CRF. levels of pro-oxidants leading to tissue damage. Pro-
oxidants are reactive species (RS) that can be divided
into reactive nitrogen species (RNS) and ROS (Table
Patients with CRF are at a high risk for developing 1). The well characterized RS are free radicals (an atom
premature CVD. Mortality from CVD in CRF patients or a molecule that contains one or more unpaired elec-
is approximately 9% per year, which is about 20–30 times trons) but non-free radical compounds can also cause
the risk in the general population, and cardiac mortality oxidative damage. Free radicals are generally highly re-
among dialysis patients younger than 45 years is about active due to their unpaired electron [3].
100 times greater than in general population [1]. This When present at physiologic concentrations, RS are
large proportional increase in risk implies that the abso- necessary for fundamental processes such as cell growth,
lute risk of cardiac death in young dialysis patients is signaling, etc. Excessive production of ROS and RNS
comparable to that observed in elderly individuals with- causes damage to biomolecules.
Antioxidant defenseKey words: cardiovascular disease, endothelial dysfunction, oxidative
stress, glutathione, LDL. Protection against RS attack can be achieved by pre-
vention of free radical formation, by blocking of chain 2003 by the International Society of Nephrology
S-50
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Table 1. Reactive species having an impact on oxidative
stress-dependent damage
Free radicals Non-free radicals
ROS O2 * H2O2
OH* HOCI
LOO* O3
O2
Hydroxyl alkenals
RNS NO* HNO2
NO2* N2O3
ONOO* Alkyl peroxynitrites (LOONO)
Abbreviations are: ROS, oxygen-based reactive species; RNS, nitrogen-based
reactive species; O2 , superoxide; OH, hydroxyl; LOO, peroxyl; NO, nitric oxide;
NO2, nitrogen dioxide; ONOO, peroxynitrite; H2O2, hydrogen peroxide; HOCI,
hydrochlorus acd; O3, ozone; O2, singlet oxygen; HNO2, nitrous acid; N2O3, dinitro-
gen trioxide; LOONO, alkyl peroxynitrites.
reactions, or by repairing oxidatively damaged molecules
[3]. There are a number of antioxidants present in the
body and derived from diet. Antioxidants can be divided
into intracellular and extracellular antioxidants. Intracel-
lular enzymatic antioxidants are superoxide dismutase
(SOD), catalase, and glutathione peroxidase, which con-
vert substrates (superoxide anion radicals and hydrogen
peroxide) to less reactive forms. The main nonenzymatic
cellular antioxidant is reduced glutathione (GSH). An
increased level of oxidized glutathione (GSSG), as well
as increased glutathione redox status (GSSG/GSH) can
serve as markers of severe cellular oxidative stress. Sev-
eral extracellular antioxidants, such as proteins trans-
ferrin, lactoferrin, albumin, ceruloplasmin, and urate,
prevent free radical reaction by sequestering transition
metal ions by chelation in plasma. Albumin, bilirubin,
Fig. 1. Reactive oxygen species (ROS) impair vascular function. Vas-
urate, and plasma ascorbic acid may also scavenge free cular function is impaired by injury to endothelial and vascular smooth
muscle cell membranes; reaction with nitric oxide (NO) and inactivation;radicals directly. Some antioxidants are located both in-
oxidization of tetrahydrobiopterin (BH4) as cofactor of nitric oxidetra- and extracellularly, such as -tocopherol, which is synthase (NOS); peroxidization of low-density lipoprotein (LDL) to
the major lipid-soluble antioxidant and is present in oxidized LDL (oxLDL); stimulation of synthesis of asymmetric dimeth-
ylarginine (ADMA)-yielding NOS inhibition; inhibition of guanylylmembranes and in plasma lipoproteins [3]. Another im-
cyclase, which leads to decreased production of cyclic guanosine mono-
portant marker that characterizes antioxidative status is phosphate (cGMP), activation of platelet aggregation and adhesion;
and oxLDL, formed under influence of ROS, which may cause upregula-the resistance of LDL to copper-catalyzed oxidation (lag
tion of receptors of adhesion molecules on endothelial cells, platelettime of LDL).
derived growth factor (PDGF) receptors on smooth muscle cells (SMC),
If antioxidant defense is compromised, elevated per- PDGF synthesis by SMC, and HLA expression on monocytes. Abbrevi-
ations are: ECM, extracellular matrix; IL-1, interleukin 1; GTP, guano-manent RS formation in the body will lead to increased
sine triphosphate; mRNA, messenger RNA.damage.
OXIDATIVE STRESS MEDIATED DAMAGE
sine monophosphate, activation of platelet aggregation,
OF VASCULATURE (ENDOTHELIUM) and adhesion, etc. (Fig. 1).
An excess production of RS has detrimental effects One of the mechanisms by which RS exert their toxic-
on the vasculature. They may injure endothelial and ity in the vasculature is oxidation of polyunsaturated
smooth muscle cell membranes, diminish levels of NO, fatty acids in the LDL particle to form oxidized LDL
oxidize tetrahydrobiopterin (BH4) as cofactor of nitric (oxLDL), which is one of the key mediators of athero-
oxide synthase (NOS), stimulate synthesis of ADMA, sclerosis [4]. The high frequency of CVD is explained
producing NOS inhibition, and inhibit guanylyl cyclase, by the OS-mediated intensive accumulation of advanced
glycation end products (AGEs). AGEs are formed by awhich leads to a decreased production of cyclic guano-
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nonenzymatic reaction of reducing carbohydrates with gies have been proposed to reduce cardiovascular morbid-
ity and mortality by improving endothelial functionalityamino groups in proteins and subsequent rearrangements
and oxidation reactions. Their accumulation may cause and reducing OS. One example of cholesterol-lowering
agents are statins, which were found to decrease markersmacro- and microangiopathy [5] and may lead to pro-
gression of atherosclerosis interaction with receptors that of inflammation, such as C-reactive protein, and to im-
prove endothelium-dependent vasodilatation [14]. Long-induce production of ROS, followed by release of in-
flammatory cytokines such as interleukin-6 [6]. chain n-3 fatty acids were shown to have effects on vascu-
lar endothelium by reducing vascular cellular adhesion
molecule (VCAM-1) cell surface and mRNA expressionOXIDATIVE STRESS IN PATIENTS WITH
[15]. Adequate intake of antioxidant vitamins C and ECHRONIC RENAL FAILURE
reduce the susceptibility of LDL to oxidation and scav-
Several studies have demonstrated increased OS in enge free radicals within the body, reducing the overall
patients with CRF, including increased concentrations of oxidative status [16]. There is also increasing evidence
thiobarbituric acid-reactive substances [7] and increased that folic acid can have a beneficial effect on the vascular
concentrations of malondialdehyde in plasma and in endothelium by reducing plasma homocysteine [17].
erythrocytes, platelets, and peripheral mononuclear cells Our recent study demonstrated that L-arginine sup-
[8] as markers of elevated lipid peroxidation. Patients plemention improved endothelium-dependent vasodila-
with CRF have significantly higher levels of conjugated tion both in patients with CRF and in healthy controls
dienes (CD) and lipid hydroperoxides (LOOH), in- [18]. Various nonpharmacologic interventions have also
creased levels of GSSG and increased redox status been shown to be beneficial in improving endothelial
GSSG/GSH and decreased resistance to oxidation of function (e.g., smoking cessation, physical exercise, etc.)
LDL (shortened lag phase of LDL) compared with [19, 20].
healthy controls [9]. All these markers indicate that pa- The mechanisms by which these strategies influence
tients with CRF have severe cellular and systemic OS endothelial function and oxidative stress are likely to be
and reduced antioxidant potency. We have also found multiple and complex.
that patients with CRF not only have significantly higher
levels of OS markers compared to healthy controls, but
also the amount of GSSG and redox ratio GSSG/GSH CONCLUSIONS
correlate significantly with serum urea and creatinine, ED and OS have an influence on vascular disease in
suggesting that glutathione redox status and GSSG levels CRF and there are emerging treatment options targeting
are related to the degree of renal failure [9]. ED and OS that may prove to be beneficial to patients
with CRF in the future.
ENDOTHELIAL DYSFUNCTION AND PATIENTS
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